TDM-105795

DRUG2 trials

Sponsors

Technoderma Medicines Inc.

Conditions

Alopecia, Androgenetic

Phase 1

A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)

CompletedNCT04913519

Technoderma Medicines Inc.Alopecia, Androgenetic

Start: 2021-04-27End: 2021-12-31Updated: 2022-04-27

A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)

CompletedNCT05244980

Technoderma Medicines Inc.Alopecia, Androgenetic

Start: 2022-02-01End: 2023-02-27Updated: 2023-03-14